Regeneration Biomedical, Inc.
PrivateLast Round
Series B
Nov 10, 2025
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Regeneration Biomedical, Inc. is a biotechnology company that develops direct-to-brain autologous stem cell therapies for the treatment of neurodegenerative diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Clinical Trials, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Regeneration Biomedical, Inc. Comparables
Compare Regeneration Biomedical, Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| UCB | 80% | |
| Aspen Neuroscience | 79% | |
| Oryon Cell Therapies | 79% |
Regeneration Biomedical, Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Nov 10, 2025 | ||||
| Series A | Jul 1, 2024 |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 26, 2026
Monthly visitors increased 90% MoM.
- Jul 1, 2024
Completed a Series A funding round.
Recent news
Latest coverage and updates
- recognized_asSep 18, 2026
Regeneration Biomedical, Inc. recognized as Fast Track designation on Sep 1st '26.
Regeneration Biomedical, Inc. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Regeneration Biomedical, Inc.'s valuation, stock price, and market status.
Is Regeneration Biomedical, Inc. a public or private company?
Regeneration Biomedical, Inc. is a private company.
What is the current stock price of Regeneration Biomedical, Inc.?
Regeneration Biomedical, Inc. is a private company with no public stock price. Caplight tracks Regeneration Biomedical, Inc.'s secondary market activity and provides MarketPrice™ estimates to Caplight users.
How much is Regeneration Biomedical, Inc. worth (valuation)?
Valuation information for Regeneration Biomedical, Inc. is not publicly available.
Can I buy Regeneration Biomedical, Inc. stock?
Regeneration Biomedical, Inc. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Regeneration Biomedical, Inc.'s last funding round?
Regeneration Biomedical, Inc.'s most recent funding round was Series B on November 10, 2025.
Who are the main investors in Regeneration Biomedical, Inc.?
Investor information for Regeneration Biomedical, Inc. is not publicly disclosed.
Will Regeneration Biomedical, Inc. IPO soon?
No public IPO plans have been announced for Regeneration Biomedical, Inc..
How can I track Regeneration Biomedical, Inc. secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Regeneration Biomedical, Inc.'s secondary market activity and sign up for updates.